Hydreight Technologies (NURS) Planet MicroCap Las Vegas 2026 summary
Event summary combining transcript, slides, and related documents.
Planet MicroCap Las Vegas 2026 summary
17 Jun, 2026Strategic vision and ecosystem development
Founded in 2018 to address fragmentation in healthcare through a B2B2C ecosystem spanning mobile health, non-traditional medical infrastructure, and direct-to-consumer virtual care.
Focused on compliance and legal guardrails, operating as a 50-state medical company with proprietary technology supporting all verticals.
Built a scalable, multidisciplinary platform with heavy investment in tech and legal infrastructure, enabling rapid expansion and operational leverage.
Emphasizes partnerships and customer onboarding, not competition, with a model validated by strong inside ownership and recurring revenue streams.
Compliance and licensure are core differentiators, attracting businesses seeking legal certainty in a tightening regulatory environment.
Business model and verticals
Three main verticals: nurse network (Uber for nurses), bricks-and-mortar medi-spas, and direct-to-consumer virtual care (VSDHOne).
Over 3,000 nurses pay annual subscriptions to join the network, validating the value proposition.
VSDHOne, launched at the end of 2024, rapidly scaled to 12,000 licenses by April 2026, with most licenses yet to be onboarded.
The direct-to-consumer vertical offers 45+ treatments, including GLP-1s and peptides, with recurring prescription sales driving growth.
Category-based onboarding for new clients ensures realistic revenue projections and operational efficiency.
Financial performance and growth
Q1 revenue of CAD 25 million, representing 70% of the prior full fiscal year, with 67% quarter-over-quarter and 450% year-over-year growth.
Trailing 12-month revenue reached CAD 55.8 million, with adjusted EBITDA margins at 13% in Q1.
Operational expenses as a percentage of revenue dropped 40% in Q1 over the previous quarter.
Cash on hand of CAD 24 million as of Q1 2026, with multiple successful financings and NCIB buybacks to support shareholder value.
Market cap at approximately CAD 241 million, with 50% inside ownership and a tightly held stock.
Latest events from Hydreight Technologies
- Record Q1 revenue up 449% YoY to CAD 24.9M, with strong growth and regulatory tailwinds.NURS
Q1 20262 Jun 2026 - 2025 revenue surged 121% to CAD 35.4M, with record EBITDA growth and robust 2026 outlook.NURS
Q4 20251 May 2026 - Q3 delivered 132% revenue growth, profitability, and rapid VSDHOne-driven expansion.NURS
Q3 202522 Apr 2026 - $10M accelerator drives rapid, compliant US digital health growth with strong margins.NURS
Status Update9 Jan 2026 - 33% YoY revenue growth, sustained profitability, and major platform expansion in H1 2025.NURS
Q2 202523 Nov 2025 - 2024 revenue hit $22.32M with profitability; 2025 targets 30% growth and expanded offerings.NURS
Q4 202421 Nov 2025 - Acquisition of Perfect Scripts stake accelerates pharmacy integration, margin growth, and scalability.NURS
Investor Update16 Nov 2025 - Q3 2024 revenue surged 54% year-over-year, with positive Adjusted EBITDA and rapid platform growth.NURS
Q3 202413 Jun 2025 - Record revenue and positive Adjusted EBITDA mark strong Q2 growth and operational progress.NURS
Q2 202413 Jun 2025